Диссертация (1141124), страница 24
Текст из файла (страница 24)
Fibronectin binding bySalmonella strains: evaluation of a particle agglutination assay //J. Clin. Microbiol . -1991. V.29. –P.2824-2830.130. Bartholomeeusen S., Vandenbroucke J., Truyers C. Buntinx F. Epidemiology andcomorbidity of erysipelas in primary care //Dermatology (Basel). -2007. -V. 215(2).
–P.118-22.131. Bernard P. Management of common bacterial infections oh the skin //Curr Op Inf Dis. 2008-V.21. –P.122-8.132. Bernard P., Bedane C., Mouneier M. et al. Bacterial dermohypodermal infection:Incidence and actual place for a streptococcal origin //Ann Dermatol Ventrlol. – 1995. – Vol.122, № 8.
– P.495-500.133. Bisno A.L., Brito M.O., Collins C.M. Molecular basis of group A streptococcalvirulence //Lancet. Infect. Dis. -2003. -Vol.3. –N.4. –P.191-200.134. Brandt C.M., Spellerberg B. Human infections due to Strepto-coccus dysgalactiaesubspecies equisimilis //Clin Infect Dis. -2009. -V. 49. -P.766–772135. Broyles L.N., Van Beneden C., Beall B. et al. Population-based study of invasivedisease due to beta-hemolytic streptococci of groups other than A and B //Clin Infect Dis. –2009. –V.48 –P.706–712124136.
Bryant A.E., Stevens D.L. Chapter 199. Streptococcus pyogenes. / In: Mandell,Douglas, and Bennett's Principles and Practice of Infectious Diseases, by Saunders, an imprint ofElsevier Inc. -2015. –P.2285-99.137. Bisno A.L., Stevens D.L. Chapter 198. Streptococcus pyogenes. /In Mandell, Douglas,and Bennett’s Principles and Practice of Infectious Diseases, 7th ed., 2009138. Bisno A.L., Stevens D.L. Streptococcal infections of skin and soft tissues.//N Engl JMed.
-1996. -Vol.334. -P.240-245.139. Bonnetblanc J.M., Bedane C. Erysipelas: recognition and management//Am. J. ClinicDermatol. -2003. -Vol.04. -№3. -P.157-163.140. Caban M., Hall L. Chapter 131. Lymphedema: in Essentials of Physical Medicine andRehabilitation. Elsevier Inc. -2015. –P. 676-80141. Caetano M, Amorim I. Erisipela //Acta Med Port. 2005;18:385-394142.
Castro M.C.R, Ramos-e-Silva, M. Fundamentos de Dermatologia. Rio de Janeiro, RJ:Atheneu. -2009. -P. 895-901143.Centers for Disease Control and Prevention (CDC) (2012) Streptococcus dysgalactiaesubsp.equisimilisemmsequencedatabase.http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm.144. Center for Drug Evaluation and Research (CDER). 2007. Uncomplicated andcomplicated skin and skin structure infections: developing antimicrobial drugs for treatment.Guidance for industry. Available at: http://www.fda.gov/cder/guidance/2566dft.pdf.145. Chartier C., Grosshans E.
Erysipelas: an update. //Int J Dermatol -1996. -Vol.35. P.779-81.146. Chen C., Krishnan V., Macon K. et al. Secreted proteases control autolysin-mediatedbiofilm growth of Staphylococcus aureus //J. Biol. Chem. -2013. –V. 288. –P.29440–29452.147. Chira S., Miller L.G. Staphylococcus aureus is the most common identified cause ofcellulitis: a systematic review //Epidemiol Infect. -2009 –V.
138(03). –P.313148. Chlebicki M.P., Oh C.C. Recurrent cellulitis: risk factors, etiology, pathogenesis andtreatment //Curr Infect Dis Rep. -2014. -V.16(9). –P. 422.149. Cichowitz A., Stanley P.A. Erysipelas-like inflammation following breast surgery // EJPlast Reconstr Aesthet Surg. -2007. -Vol.60. -№5. -р.490-494.150. Cogen A.L., Yamasaki K., Muto J. Et al. Staphylococcus epider-midis antimicrobialdelta-toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to killgroup A Streptococcus //PLoS One. -2010. –V.
5(1) –P.e8557.125151. Cogen A.L., Yamasaki K., Sanchez K.M. et al. Selective Antimic-robial Action IsProvided by Phenol-Soluble Modulins Derived from Staphy-lococcus epidermidis, a NormalResident of the Skin. //J Invest Dermatol -2009.152. Cohen-Poradosu R., Jaffe J., Lavi D. et al. Group G streptococcal bacteremia inJerusalem //Emerg Infect Dis.
– 2004. –V.10. –P.1455–1460153. Conti E., Tositti G., Fausto de Lalla. Erysipelas and cellulitis: clinical andmicrobiological spectrum in an Italian tertiary care hospital //J Infect. -2005. –V.51(5).-P.25-30.154. Cookson B., Schmitz F., Fluit A.. Introduction In: A.C. Fluit and F.J. Schmitz, Editors,MRSA.
Current Perspectives, Caister Academic Press, Wymondham. – 2003. -P.1-9.155. Cosgrove S.E., Sakoulas G., Perencevich E.N., et al..Comparison of mortalityassociated with methicillin-resistant and methicillin-susceptible Staphylococcus aureusbacteremia: a meta-analysis //Clin Infect Dis. -2003. V.-36(1). -P.53-59.156. CrickxB. Erysipelas: evolution under treatment, complications. Hospital //Ann.Dermatol. Venereol. -2001.-Vol.128 .-P.358-362.157.
Crum N.F., Lee R.U., Thornton S.A. et al. Fifteen-year study of the changingepidemiology of methicillin-resistant Staphylococcus aureus //Am J Med. -2006. –V.119. –P.943–951.158. Crupper S.S., Iandolo J.J.. Purification and partial characterization of a novelantibacterial agent (Bac1829) produced by Staphylococcus aureus KSI1829 //Appl.
Environ.Microbiol. - 1996. -V.62. -P.3171-3175.159. Cunningham M.W. Pathogenesis of Group A Streptococcal infections //ClinicalMicrobiology Reviews. -2000. -Vol.13. -№3. -P.470-511.160. Dale J.B., Fischetti V.A.., Carapetis JR. et al. Group A streptococcal vaccines: paving apath for accelerated development //Vaccine. -2013 -V.18/ № 31.
- Suppl 2:B2 –P.16-22.161. Damstra R.J., Van Steensel M.A.M., Boomsma J.H.B. et al. Erysipelas as a sign ofsubclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patientswith unilateral erypelas of the leg //Br J Dermatol. -2008 –V.12. -P.10-15.162. Dangoisse C , Ledoux M. Recurrent erysipelas //Rev Med Brux. -1991.
–V.12(7).P.253-256.163. Davies M.R., McMillan D.J., Beiko R.G. et al. Virulence profiling of Streptococcusdysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct geneticlineages that do not segregate with their phenotypes or propensity to cause diseases //Clin InfectDis -2007 -V. 44. –P.1442–1454164. Denis F., Martin C., Ploy M.C. L′erysipele: donnees microbiologiques et patogeniques//Ann Dermatol. Ventrlol. – 2001. –V..128. -P.317-325.126165.
Denis O., Simonart T. Involvement of Staphylococcus aureus in erysipelas//Dermatology. -2006. –V. 212(1). -P.1-3.166. Diamantis M.L., Ortega-Loayza A.G., Morrell D.S. Update on the characterization ofStaphylococcus aureus skin infections in a pediatric dermato-logy tertiary health care outpatientfacility: antibiotic susceptibility patterns and decreased methicillin resistance //J. Am. Acad.Dermatol.
-2011. –V.64. –P.440–441.167. Didenko L.V., Andreevskaya S.G., Konstantinova N.D., Buchwalow I.B.Ultrastructure of circulating immune complexes isolated from the blood plasma of patientssuffering from infectious diseases //Journal of Basic Microbiology. -1995. –V.35. -№ 3. -P.63.168. Dietrich D.W., Auld D.B., Mermel L.A. Community-acquired methi-cillin-resistantStaphylococcus aureus in southern New England children //Pediatrics. -2004 –V.113 –P.e347–e352.169. Digeon, M., Laver, M. and Riza, I.
Detection of circulating immune complex in humansera by simplified assay with polyethylene glycol //J. Immunol. Methods. – 1977. –V.16. –P.165-183.170. DiNubile M.J., Lipsky B.A. Complicated infections of skin and skin structures: whenthe infection is more than skin deep //J Antimicrob Chemother -2004 -53(Suppl 2).
-P.11371150.171. Dryden M. Complicated skin and soft tissue infections caused by methi-cillin-resistantStaphylococcus aureus: epidemiology, risk factors, and presen-tation //Surg Infect (Larchmt). 2008. –V. 9( Suppl 1). –P.s3-10.172. Dryden M.S.. Skin and soft tissue infection: microbiology and epidemiology //Int JAntimicrob Agents. -2009. –V.34 (Suppl 1). -P.S2–S7.173. Dupuy А., Benchikhi Н., Roujeau J-C. et al. Risk factors for erysipelas of the leg(cellulitis):case-control study //BMJ. -1999. - Vol.318. -№4. –P.1591-1594.174.
Edelsberg J., Taneja C., Zervos M. et al. Trends in US hospital admis-sions for skin andsoft tissue infections //Emerg Infect Dis.-2009. –V.15. –P.1516–1518.175. Ekelund K., Skinhøj P., Madsen J. et al. Invasive group A, B, C and G streptococcalinfections in Denmark 1999– 2002: epidemiological and clinical aspects //Clin Microbiol Infect.– 2005 –V.11. –P. 569–576176.
El Saghir N. S., Otrock Z.K., Bizri A.R. et al. Erysipelas of the upper extremityfollowing locoregional therapy for breast cancer //Breast. - 2005. - V. 14, № 5. - P.347-351.127177. Empinotti J.C., Uyeda H., Ruaro R.T. et al. Pyodermitis //An Bras Dermatol. -2012. –V. 87(2). –P.277-84.178. Eriksson B., Jorup-Rönström C., Karkkonen K. et al. Erysipelas: clinical andbacteriologic spectrum and serological aspects //Clin Infect Dis. -1996.
-Vol.23. -P.1091-1098.179. Eron L.J., Lipsky B.A., Low D.E., et al. Managing skin and soft tissue infections: expertpanel recommendations on key decision points //J Antimicrob Chemother. -2003. –V.52(Suppl1). -P.13-17.180. Facklam R.What happened to the streptococci: overview of taxonomic andnomenclature changes //Clin Microbiol Rev. - 2002. -V.15. -P.613- 630181.
Farley J.E.. Epidemiology, clinical manifestations, and treatment opti-ons for skin andsoft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus//J Am Acad Nurse pract. -2008. -20. -P.85–92.182. Figtree, M., KonecnyP., Jennings Z.et al. Risk stratification and out-come of cellulitisadmitted to hospital //J Infect. -2010. -Vol.60(6) -P.431-439.183.
Finelli L., Fiore A., Dhara R. et al. . Influenza-associated pediatric mortality in theUnited States: increase of Staphylococcus aureus coinfection //Pediatrics - 2008. –V. 122. –P.805–811.184. FischerW., Koch H. U., Haas R. Improved Preparation of Lipoteichoic Acids//Biochem. -1983. -Vol.133. –P.523-530.185. Fischetti V.A. Streptococcal M protein: molecular design and biological behavior //ClinMicrobiol Rev. – 1989.
–V.2. –P.285–314186. Fontaine M.C., Lee J.J., Kehoe M.A. Combined contributions of strep-tolysin O andstreptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo //Infect.Immun. - 2003. -Vol. 71. -№7. -P.3857-3865.187.Frank D.N., Feazel L.M., Bessesen M.T.Thehumannasalmicrobiotaand Staphylococcus aureus carriage //PLoS One. – 2010. $ 5:e10598.188. Freedberg I.M., Eisen A.Z., Wolff K.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
